# Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

> **NCT00980681** · PHASE3 · TERMINATED · sponsor: **Guerbet** · enrollment: 13 (actual)

## Conditions studied

- Renal Disease

## Interventions

- **DRUG:** Dotarem
- **OTHER:** Time of Flight

## Key facts

- **NCT ID:** NCT00980681
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Lack of recruitment.
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980681, "Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00980681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*